Medicare Enrolled

Dr. Mohammad Riaz, MD

Medical Oncology · Katy, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
410 W GRAND PKWY S STE 4C, Katy, TX 77494
2816477766
In practice since 2006 (20 years)
NPI: 1619947421 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Riaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riaz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Riaz

Dr. Mohammad Riaz is a medical oncology in Katy, TX, with 20 years in practice. Based on federal Medicare data, Dr. Riaz performed 10,252 Medicare services across 525 unique beneficiaries.

Between the years covered by Open Payments, Dr. Riaz received a total of $6,841 from 69 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Riaz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 41% volume in TX$ $6,841 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,252
Medicare services
Top 41% in TX for medical oncology
525
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~513 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)5,820$17$49
Anti-nausea injection (Aloxi/palonosetron)1,510$1$26
Infusion, normal saline solution, sterile (500 ml = 1 unit)488$1$16
Administration of chemotherapy into vein, each additional hour363$23$64
Office visit, established patient (30-39 min)287$95$241
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less256$23$69
Administration of chemotherapy into vein, 1 hour or less236$105$309
Administration of additional new drug or substance into vein, 1 hour or less234$52$146
Infusion into a vein for hydration, each additional hour232$10$34
Injection, diphenhydramine hcl, up to 50 mg203$1$1
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle178$58$166
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour165$17$41
Injection, hydrocortisone sodium succinate, up to 100 mg154$14$28
New patient office visit, complex (60-74 min)44$171$478
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less37$49$153
Drug injection, under skin or into muscle23$11$59
New patient office visit (45-59 min)22$110$343
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
82.8% medium
5.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,841
Total received (2018-2024)
Avg $977/year across 7 years
Top 42% in TX for medical oncology
69
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,554 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$287 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$159
2023
$392
2022
$514
2021
$1,303
2020
$983
2019
$1,581
2018
$1,909

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$976
Merck Sharp & Dohme Corporation
$554
E.R. Squibb & Sons, L.L.C.
$398
Celgene Corporation
$328
TerSera Therapeutics LLC
$300
Lilly USA, LLC
$271
AstraZeneca Pharmaceuticals LP
$263
Janssen Biotech, Inc.
$233
Takeda Pharmaceuticals U.S.A., Inc.
$187
Taiho Oncology, Inc.
$184
Genentech USA, Inc.
$180
Bayer HealthCare Pharmaceuticals Inc.
$155
PFIZER INC.
$154
Novartis Pharmaceuticals Corporation
$153
Daiichi Sankyo Inc.
$147
Verastem, Inc.
$135
GENZYME CORPORATION
$118
Mylan Institutional Inc.
$95
INSYS Therapeutics Inc
$91
TAIHO ONCOLOGY, INC.
$87
Exelixis Inc.
$77
AMAG Pharmaceuticals, Inc.
$77
Clovis Oncology, Inc.
$76
Myovant Sciences Inc.
$70
Rigel Pharmaceuticals, Inc.
$69
Pharmacyclics LLC, An AbbVie Company
$67
Pharmacosmos Therapeutics Inc.
$65
Teva Pharmaceuticals USA, Inc.
$59
Ipsen Biopharmaceuticals, Inc
$58
Regeneron Healthcare Solutions, Inc.
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
TESARO, Inc.
$57
Janssen Pharmaceuticals, Inc
$53
Octapharma USA, Inc.
$49
Myriad Genetic Laboratories, Inc.
$46
Kyowa Kirin, Inc.
$46
Eisai Inc.
$44
Seagen Inc.
$43
Coherus Biosciences Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$40
Merck Sharp & Dohme LLC
$40
EISAI INC.
$40
JAZZ PHARMACEUTICALS INC.
$37
BeiGene USA, Inc.
$37
EMD Serono, Inc.
$35
Shield Therapeutics Inc
$33
Secura Bio, Inc.
$31
Organon LLC
$31
Dova Pharmaceuticals
$29
Medtronic USA, Inc.
$29
Puma Biotechnology, Inc.
$29
Sysmex Inostics Inc
$27
Otsuka America Pharmaceutical, Inc.
$22
Epizyme, Inc.,
$22
Ethicon US, LLC
$21
AbbVie Inc.
$20
R-Pharm US LLC
$20
Mirati Therapeutics, Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$18
Gilead Sciences, Inc.
$18
GRT US Holding, Inc.
$18
Astellas Pharma US Inc
$15
Advanced Accelerator Applications
$15
MEDELA LLC
$14
Boston Scientific Corporation
$13
Emmaus Medical, Inc.
$13
GlaxoSmithKline, LLC.
$13
Seattle Genetics, Inc.
$12
APO-PHARMA USA, INC.
$12
Top 3 companies account for 28.2% of total payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · BENDEKA · BRUKINSA · Balversa · Bavencio · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DEFERIPRONE · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · Echelon Circular · Endari · Enhertu · Erleada · FERAHEME · Farydak · Fulphila · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · Ixempra · JADENU · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUX-Dx Insertable Cardiac Monitor · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MVASI · MYRISK · Monoferric · NERLYNX · NEXPLANON · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ONUREG · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · Ogivri · PADCEV · PANZYGA · PIQRAY · POTELIGEO · PROMACTA · Polivy · Pomalyst · Prolia · Qutenza · REBLOZYL · RETACRIT · RYBREVANT · Revlimid · Rubraca · SANCUSO · SANDOSTATIN LAR · SOMATULINE DEPOT · SPRYCEL · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TREMFYA · Tavalisse · Tecentriq · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · Xermelo · ZEJULA · ZOLADEX · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $67 per 100 Medicare services performed
Looking for a medical oncology in Katy?
Compare medical oncologys in the Katy area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
174
Per 100K population
20.2
County median income
$113,409
Nearest hospital
MEMORIAL HERMANN KATY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Riaz is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Riaz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Riaz performed 5,820 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Riaz receive payments from pharmaceutical companies?
Yes. Dr. Riaz received a total of $6,841 from 69 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riaz's costs compare to other medical oncologys in Katy?
Dr. Riaz's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →